Volver a los detalles del artículo RETATRUTIDE: REGULATORY CHALLENGES, PATIENT SAFETY, AND THE IMPACT OF THE ILLICIT SALE OF AN INVESTIGATIONAL DRUG FOR THE TREATMENT OF OBESITY Descargar Descargar PDF